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Abstract Cavins belong to a family of proteins that contrib-
ute to the formation of caveolae, which are membrane organ-
elles with functional roles in muscle and fat. Here, we inves-
tigate the effect of cavin-3 ablation on vascular and urinary
bladder structure and function. Arteries and urinary bladders
from mice lacking cavin-3 (knockout: KO) and from controls
(wild type: WT) were examined. Our studies revealed that the
loss of cavin-3 resulted in ∼40% reduction of the caveolae
protein cavin-1 in vascular and bladder smooth muscle.
Electron microscopy demonstrated that the loss of cavin-3
was accompanied by a reduction of caveolae abundance by
40-45% in smooth muscle, whereas the density of caveolae in
endothelial cells was unchanged. Vascular contraction in re-
sponse to an α1-adrenergic agonist was normal but nitric-
oxide-dependent relaxation was enhanced, in parallel with
an increased relaxation on direct activation of soluble
guanylyl cyclase (sGC). This was associated with an elevated
expression of sGC, although blood pressure was similar in
WT and KO mice. Contraction of the urinary bladder was
not affected by the loss of cavin-3. The proteomic response
to outlet obstruction, including STAT3 phosphorylation, the
induction of synthetic markers and the repression of contrac-
tile markers were identical in WT and KO mice, the only
exception being a curtailed induction of the Golgi protein
GM130. Loss of cavin-3 thus reduces the number of caveolae
in smooth muscle and partly destabilizes cavin-1 but the func-
tional consequences are modest and include an elevated
vascular sensitivity to nitric oxide and slightly disturbed
Golgi homeostasis in situations of severe cellular stress.
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Introduction
Many cell types, such as vascular smooth muscle cells and
endothelial cells, are abundantly endowed with small plasma
membrane invaginations termed caveolae. These structures,
which are rich in cholesterol and sphingolipids, might act as
signaling platforms for receptors that convey messages from
the surrounding environment into the cell (Parton and del
Pozo 2013). Caveolae are generated by proteins that are
inserted into the inner leaflet of the cell membrane. These
proteins are called caveolins (Cav-1 to Cav-3) and associate
with cytosolic proteins called cavins (cavin-1 to cavin-4). The
latter proteins form a complex that aid in the formation of
caveolae by providing a stabilizing cytoplasmic coat.
Caveolin-1 was the first caveolae protein to be discovered
and was identified as being necessary for caveolae to form.
The cavins were discovered more recently and their require-
ment for the formation of caveolae is cell-type-dependent.
Deficiency in either caveolin-1 or cavin-1 results in the com-
plete absence of caveolae, together with the breakdown of
other caveolae proteins. The role of cavin-2, -3 and -4 has
been less well investigated but a recent study demonstrated
that a lack of cavin-2 results in the loss of endothelial
caveolae in the lung (but not in the heart), whereas the loss
of cavin-3 has no effect on endothelial or fibroblast caveolae
(Hansen et al. 2013; Liu et al. 2014). Another study indicated
that the knockdown of cavin-3 reduces caveolae by 87% in a
human fibroblast cell line (Hernandez et al. 2013). These
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findings reinforce the view that the less well-studied cavins,
namely cavin-2 and -3, contribute to caveolae in a cell- or
species-specific manner, although an in vivo role for cavin-3
in the formation of caveolae has yet to be definitively
established.
Cavin-3 was originally identified as a protein that binds to
protein kinase C-δ and hence, its gene name is PRKCDBP for
Protein Kinase C Delta Binding Protein. The stability of
caveolins and cavins has been found to depend on the pres-
ence of the caveolar protein complex and caveolins and cavins
are targeted for degradation in the absence of this stabilizing
structure. Accordingly, cavin-3 expression depends on cavin-
1 and on caveolin-1 but not on cavin-2 (Hansen et al. 2013).
Studies have shown that cavins form trimers that can be com-
posed either of three cavin-1 molecules or of a mix of two
cavin-1 molecules with one cavin-2 or one cavin-3 molecule
(Ludwig et al. 2013; Kovtun et al. 2014). These trimers are
then used as building blocks in higher-order assembly
(Stoeber et al. 2016). Because cavin-1 and cavin-2 can substi-
tute for cavin-3 in such trimers, the lack of cavin-3 might be
compensated for by other cavins that are present at adequate
concentrations. A reasonable starting point in the search of a
role for cavin-3 for caveolae formation in vivo should thus be
to identify tissues expressing high levels of cavin-3 compared
with other cavins.
Here, we sought to establish the role of cavin-3 in caveolae
formation in vivo. To this end, we surveyed cavin-3 expres-
sion and found it to be preferentially expressed in smooth
muscle. In keeping with this tissue distribution, we found that
caveolae were less abundant in vascular and urinary bladder
smooth muscle cells from cavin-3-deficient mice. The physi-
ological consequences of cavin-3 deficiency were mild, how-
ever, involving increased vascular relaxation in response to a
nitric oxide (NO) donor and slightly higher expression of sol-
uble guanylyl cyclase (sGC). Growth and protein expression
in the urinary bladder in response to outlet obstruction, a mod-
el of distension-induced growth, were nevertheless largely
unchanged. These studies establish a role of cavin-3 in the
formation of caveolae in vivo but also show that the physio-
logical consequences of cavin-3 ablation are modest.
Materials and methods
Animals
Mice, namelyPrkcdbp knockout (KO) and wild-type (WT) on
a B6.12954 background, were purchased from the Jackson
Laboratory and were propagated (KO × KO, WT × WT) and
housed in the animal facility at BMC in Lund, Sweden. Both
KO andWTmice bred well and no dramatic difference in litter
size was apparent. Mice were kept on a 12/12 h dark/light
cycle and had free access to food and water. Animals were
used at an age between 10–20 weeks. The experimental proto-
cols were approved by the local Malmö/Lund Ethics
Committee (M433-12 and M46-13) at Lund University and
all efforts were made to minimize suffering.
Transmission electron microscopy
Small mesenteric arteries were fixed by immersing the tissue
in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer
(pH 7.4). Urinary bladders were excised from perfusion-
fixed animals. Briefly, each mouse was anesthetized by
isoflurane (4%) and the thoracic cavity was opened. A small
incision was made in the left ventricle, a catheter was ad-
vanced into the aorta and another incision was made in the
right atrium. After washes with phosphate-buffered saline
(PBS), fixative was infused into the mouse and the bladder
was excised. The tissues were post-fixed in 1% osmium te-
troxide for 2 h, stained with uranyl acetate, dehydrated and
embedded in Araldite. Sections were first stained with tolui-
dine blue to choose areas to be cut for electron microscopy.
Images of endothelial cells and the underlying smooth muscle
cells were taken at 60 K magnification in a JEOL JEM 1230
microscope (Jeol, Tokyo, Japan). Caveolae were quantified by
tracing the cell membrane in the images and counting the
vesicles with a size of 50–100 nm that resided within
100 nm from the cell membrane by using ImageJ (NIH,
Bethesda, Md., USA).
Immunohistochemistry
Small mesenteric arteries, caudal arteries and urinary bladders
were fixed in 4% paraformaldehyde and embedded in paraf-
fin. Sections (5 μm thick) were cut, mounted on slides and
deparaffinized. Sections were incubated overnight (4 °C) with
primary antibodies dissolved in PBS (pH 7.2) containing 3%
bovine serum albumin and 0.25% Triton X-100. The primary
antibody used was rabbit anti-cavin-3 (16250-1-AP,
Fig. 1 Cavin-3 (PRKCDBP protein kinase C delta binding protein) is
highly expressed in arterial smooth muscle cells and contributes to the
formation of caveolae. To identify tissues expressing high levels of cavin-
3 (PRKCDBP), we analyzed mRNA expression data from
GTExPortal.org (a), showing preferential expression in arteries (white
bars). b–b’’ Small mesenteric and caudal arteries from mice were sub-
jected to immunofluorescence staining by using an antibody against
cavin-3 (red). Nuclei were stained with DAPI (blue) and elastic laminae
were visualized by using autofluorescence (green). Cavin-3 appeared
specific for the medial smooth muscle cells as shown in the images at
higher magnification (b’, b’’). Bars 25 μm. c Representative electron
micrographs of small mesenteric arteries from wild-type (WT) and
cavin-3 knockout (KO) mice. c, c’ Caveolae in endothelial cells (EC).
c’’, c’’’ Caveolae in smooth muscle cells (SMC). Selected caveolae are
highlighted in pink. Bars 500 nm. d Number of caveolae per micrometer
plasma membrane in endothelial and smooth muscle cells analyzed in
three mice per genotype and covering total membrane lengths of 485
and 479 μm in WT and KO, respectively. ***P < 0.001
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ProteinTech group, Chicago, Ill., USA) and sections were
subsequently rinsed (2 × 10 min) in PBS with 0.25% Triton
X-100 followed by incubation with secondary antibody. For
fluorescence imaging, secondary antibodies with specificity
for rabbit and coupled to Cy2 (Jackson, West Grove, Pa.,
USA) were used and nuclei were stained with 4,6-
diamidino-2-phenylindole (DAPI). Fluorescence micrographs
were captured via an Olympus DP72 microscope equipped
w i t h a d i g i t a l c ame r a and by u s i ng O lympus
CellSensDimension software. For immunohistochemistry of
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the bladder, the tissue was blocked with 4%H2O2 in methanol
for 20 min at room temperature to inhibit endogenous perox-
idase activity. Visualization of cavin-3 expression was per-
formed by using secondary antibodies conjugated with HRP
(horseradish peroxidase; Cell Signaling) at a 1:200 dilution
and nuclei were counterstained with hematoxylin (Histolab).
Western blotting
Arteries and bladders were homogenized in 70 μl SDS-
buffer (62.5 mM TRIS–HCl pH 6.8, 2% SDS (w/v), 10%
(v/v) glycerol, protease inhibitor, phosphatase inhibitor)
by using a Tissue Lyser (Qiagen) as descr ibed
(Turczynska et al. 2012). Samples (5-20 μg) were sepa-
rated on Criterion TGX Precast Gels (Bio-Rad) and pro-
teins were transferred to nitrocellulose membranes by
us ing the Trans-Blo t Turbo sys tem (Bio-Rad) .
Visualization of proteins of interest was performed by
subject ing the membrane to primary ant ibodies
(caveolin-1, Cell Signaling; cavin-1, cavin-2 and cavin-
3, Abcam; GAPDH, Millipore; GUCY1A3, Thermo
Scientific; GUCY1B3, Proteintech). Appropriate second-
ary antibodies (Cell Signaling) were employed and finally,
the membranes were developed by using SuperSignal
West Femto Substrate (Thermo Scientific). The resulting
chemiluminescence was analyzed by using Fc Odyssey
(Li-Cor) and Image Scope software.
Vascular reactivity
The tail artery or the small mesenteric arteries were dissected
in Ca2+-free HEPES (135.5 mM NaCl, 5.9 mM KCl, 1.2 mM
MgCl2, 2.5 mM CaCl2, 11.6 mM glucose, 11.6 mM HEPES,
pH 7.4), mounted in wire myographs (DMT) and stretched to
5 mN (Sward et al. 2014). All vessels were contracted twice at
25 min intervals with 60 mM K+ HEPES, before the protocol
was started. Tail arteries were contracted with incremental
doses of cirazoline (3 × 10−9-10−6 M) and relaxed by using
Fig. 2 Destabilization of cavin-1
(PTRF) in the vascular wall in
cavin-3-deficient mice. Protein
expression was determined by
Western blotting in aorta (a, b-b’’;
n = 9 per group), in small
mesenteric arteries (c, d-d’’; n = 3
per group) and in caudal artery (e,
f-f’’; n = 5 WT, n = 6 KO) from
WT and KO mice. Protein (5 or
20 μg) was separated on SDS-
polyacrylamide gels and
transferred to nitrocellulose
membranes that were incubated
with antibodies recognizing the
various caveolae-associated
proteins, namely caveolin-1
(CAV1), cavin-1 (PTRF) and
cavin-3 (PRKCDBP). Heat-
senstive protein 90 (HSP90) was
used as a loading control.
*P < 0.05, **P < 0.01 and
***P < 0.001
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incremental concentrations of carbachol (10−8-10−4 M) in the
presence or absence of L-NAME (L-NG-nitroarginine methyl
ester; 3 × 10−7 M). After contraction with 10−6M cirazoline,
relaxation in response to SNP (sodium nitroprusside; 10−8-
10−5 M) and the cGMP activator BAY 41–2272 (3 × 10−9- 3
× 10−6 M) was investigated in tail arteries. Small mesenteric
arteries were subjected to the vasoconstrictors serotonin (2 ×
10−6 M) or angiotensin II (Ang-II; 3 × 10−6 M). Small mes-
enteric arteries were also mounted in a pressure myograph
system in Ca2+-free solution containing 2 mM EGTA.
Passive vessel diameter was measured in response to incre-
mental elevation in pressure (45–120 mmHg).
Blood pressure measurements
Blood pressure was measured in conscious mice by using a
tail-cuff system (CODA, Kent Scientific) as described
(Krawczyk et al. 2015). Mice (WT and KO) were adapted to
the holders and the cuffs on three different occasions,
Fig. 3 Nitric-oxide-dependent component of dilation is increased and L-
NAME-resistant component of dilation is reduced in absence of cavin-3.
Arteries from WT and cavin-3-deficient (KO) mice were dissected and
mounted in wire-myographs for force recordings. Contraction was
induced in caudal arteries by using incremental doses of the α1-
adrenergic agonist cirazoline (n = 9; HK high-potassium; a). After a
maximal contraction in response to cirazoline, relaxation to incremental
doses of acetylcholine was assessed in the absence and presence of the
nitric oxide synthase inhibitor L-NAME (Cch carbachol; b, c). Arteries
were also relaxed by cumulatively increasing concentrations of sodium
nitroprusside (SNP; n = 9; d) and the soluble guanylyl cyclase (sGC)
activator BAY 41–2272 (n = 6; e). Contraction in response to high-
potassium (HK, 60 mM K in HEPES) was assessed before the start of
the experiments (f). Contraction in response to angiotensin II (AngII) and
5-HT (n = 9 per group) was assessed in the small mesenteric artery (g, h).
Systemic blood pressure (MAP mean arterial pressure) was assessed in
conscious mice by using a tail-cuff system (i). Expression of the two sGC
subunits Gucy1a3 and Gucy1b3 was measured by Western blotting
(HSP90 heat-sensitive protein 90; j-j’’). Small mesenteric arteries were
also dissected and mounted in a pressure myograph under calcium-free
conditions. Pressure was increased incrementally, vessel diameter was
measured and distensibility was calculated (k, l). *P < 0.05, **P < 0.01,
***P < 0.001, n.s. not significant
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separated by at least 3 days, before the actual blood pressure
measurement.
Partial bladder outlet obstruction
Mice were subjected to partial bladder outlet obstruction as
described (Shakirova et al. 2010). Briefly, mice were anesthe-
tized by using isoflurane (2%) and outlet obstruction was
achieved by tying 6–0 Prolene around the urethra and a 0.4-
mm stainless steel spacer via an abdominal incision.
Following the placing of the Prolene, the spacer was removed,
creating a standardized partial obstruction. Sham-operated
mice, undergoing the same procedure but without tightening
of the ligature, were used as controls. Mice were killed after
7 days by using increasing CO2 and bladders for biochemical
analyses were rapidly excised, emptied and immersed in liq-
uid N2. Bladder lysates were then prepared as described
above.
Statistics
Means ± SEM are depicted in the figures. Single comparisons
were made by using a two-tailed Student’s t-test.
Concentration response curves were compared by using
RAMNOVAs and multiple comparisons were made by using
ANOVAs followed by Bonferroni post-hoc tests. RNA-Seq
data from the GTExPortal was downloaded and TMM-
normalized as described (Krawczyk et al. 2015). All analyses
were made by using GraphPad Prism; n denotes the number of
animals. P < 0.05 was considered as significant (*P < 0.05,
**P < 0.01 and ***P < 0.001).
Results
Cavin-3 deficiency results in reduced number of caveolae
in vascular smooth muscle cells
To explore the tissue distribution of cavin-3, we used RNA-Seq
data from the GTEx Portal (http://www.gtexportal.org/). We
found that human arteries (aorta, tibial artery and coronary
artery) expressed the highest levels of cavin-3 mRNA among
all tissues represented in the database (Fig. 1a shows the top 20
expressing tissues). Because arteries contain various cell
Fig. 4 Reduced density of caveolae in bladder smooth muscle from
cavin-3 knockout mice. Following perfusion fixation, urinary bladders
from wild-type (WT) and cavin-3-deficient (KO) mice were excised and
prepared for electron microscopy. a, b Electron micrographs of detrusor
myocytes from WT (a) and KO (b) mice. Caveolae are highlighted in
pink. Bars 500 nm. c Number of caveolae per micrometer plasma
membrane in bladder smooth muscle cells from three mice per
genotype and covering total membrane lengths of 583 and 614 μm in
WT and KO, respectively. *P < 0.05
Cell Tissue Res
populations (smooth muscle, endothelial and adventitial cells),
we next stainedmouse arteries to determine in which cells cavin-
3 was expressed. We found the medial smooth muscle layer
between the elastic laminae (green, Fig. 1b) to be positive for
cavin-3 (red). No staining of endothelial cells inside the internal
elastic lamina was apparent. Adventitial cells were similarly neg-
ative. We next compared the membrane density of caveolae in
endothelial and smooth muscle cells in small mesenteric arteries
from WT and KO mice by using electron microscopy (Fig. 1c).
The density of caveolae in endothelial cells was similar in WT
andKOmice (Fig. 1c’ vs. c’’, d), whereas the caveolae density in
smooth muscle cells was reduced by ≈ 40% (Fig. 1c’’ vs. c’’’, d).
We concluded that cavin-3 contributed to the biogenesis of ca-
veolae in vascular smooth muscle cells in vivo.
Loss of cavin-3 reduces expression of cavin-1 in arteries
Knock-down of either caveolin-1 or cavin-1 typically
results in reduced levels of other caveolae-associated proteins.
We therefore next explored whether the loss of cavin-3 had
any effect on the expression of other caveolae proteins in three
different arteries (aorta, small mesenteric artery, caudal ar-
tery). We found that cavin-1 (polymerase I transcription and
release factor, PTRF) was significantly reduced in all of these
arteries (Fig. 2a-f). Caveolin-1 similarly tended to be reduced
throughout but this difference reached significance only in
the caudal artery (Fig. 2e, f), which is a comparatively mus-
cular artery. We concluded that the lack of cavin-3 was asso-
ciated with reduced levels of cavin-1 at the tissue level.
Fig. 5 Cavin-3 is expressed in
detrusor myocytes and its absence
is associated with reduced
expression of caveolin-1,
caveolin-3 and cavin-1 but leaves
contractility unchanged. Bladders
from wild-type (WT) and cavin-3-
deficient (KO) mice were
processed for
immunohistochemistry with
cavin-3 antibody (n = 3 per group;
a–d). Cavin-3 (brown) was
mostly localized to smooth
muscle cell membranes, as shown
in the high-magnification cross-
section in b and was absent from




and ERK were determined by
Western blotting (e, e’; n = 13 per
group). Contraction of bladder
strips following treatment with
increasing concentrations of
carbachol was measured (f; n = 6
per group). Force was normalized
to depolarization-induced
contraction (HK) but similar
results were obtained when
absolute force was plotted (not




Increased sensitivity to NO in cavin-3 KO mice
Vascular smooth muscle cells contract and regulate arteri-
al diameter and this is considered to depend on caveolae.
We therefore mounted arteries from WT and KO mice in
wire and pressure myographs to assess arterial function
directly. Contraction in response to the α1-adrenergic ag-
onist cirazoline was similar in WT and cavin-3 KO arter-
ies (Fig. 3a), as was total relaxation in response to the
muscarinic agonist carbachol (Fig. 3b). In the presence
of the NO synthase inhibitor L-NAME, pre-contracted
KO vessels showed a reduced ability to relax in response
to charbachol (Fig. 3c), suggesting a larger nitric-oxide-
dependent component (i.e., relaxation in the absence of L-
NAME minus relaxation in the presence of L-NAME).
This was further assessed by investigating relaxation in
response to an NO-donor (SNP) and a guanylyl cyclase
activator (BAY 41–2272). We found that cavin-3 KO ar-
teries were significantly more sensitive to SNP and to
BAY 41–2272 (Fig. 3d, e) compared with WT arteries.
Contraction in response to depolarization and angiotensin
II was unaffected by the lack of cavin-3 (Fig. 3f, g),
whereas contraction in response to 5-HT was reduced
(Fig. 3h). To assess whether these changes in vascular
function had any physiological consequences, we mea-
sured the blood pressure of conscious mice; no difference
in blood pressure between WT and KO mice was detect-
able (Fig. 3i). To examine further the basis of the en-
hanced relaxation by SNP and BAY 41–2272, both of
which activate sGC in smooth muscle cells, we deter-
mined the expression of Gucy1a3, one of the subunits of
sGC and found it to be increased (Fig. 3j, j’). Gucy1b3
tended also to be increased but this was not significant
(Fig. 3j’’). Measurements of passive vessel characteristics
in the pressure myograph revealed no clear-cut differences
in either vessel diameter or in distensibility (Fig. 3k, l).
Taken together, these experiments showed that the lack of
cavin-3 was associated with increased relaxation in re-
sponse to the activation of sGC in vitro but that in vivo,
this was compensated for such that overall endothelial-
dependent relaxation and blood pressure remained similar.
Some, but not all, responses to agonists at G-protein-
coupled receptors were moreover reduced.
Cavin-3−/− mice have reduced amount of caveolae
in bladder smooth muscle but show no change
during muscarinic contraction
To assess whether the reduction of caveolae density in cavin-
3-deficient mice applied to other smooth muscles, we exam-
ined the urinary bladder. We found that cavin-3 KO mice had
approximately 45% fewer caveolae in bladder smooth muscle
cells compared withWTmice (Fig. 4a-c). Staining for cavin-3
in WT mice was intense in membranes of the smooth muscle
layer but this was completely absent in KO mice (Fig. 5a–d).
Some staining in the mucosa and of a rare cell type in the
muscle layer remained in KO mice, suggesting that the anti-
body bound to additional but less abundant, epitopes under
some conditions. The expression of caveolin-1, caveolin-3
and cavin-1 was significantly reduced in KO bladder, as
shown by Western blotting (Fig. 5e). We also measured total
extracellular signal-regulated kinase (T-ERK) and phosphor-
ylated ERK (P-ERK) and found a slight decrease in P-ERK in
KO mice (Fig. 5e, e’). To assess whether the reduction of
caveolae had contractile consequences, we measured force
in response to stimulation with the muscarinic agonist carba-
chol but found no significant difference between genotypes
(Fig. 5f). We concluded that the lack of cavin-3 was also
associated with a reduction of caveolae in urinary bladder
smooth muscle cells.
Cavin-3 deficiency does not affect bladder growth
but diminishes induction of Golgi protein GM130
in response to partial bladder outlet obstruction
Since the lack of cavin-3 did not affect detrusor function, we
decided to stress the system by inducing partial bladder outlet
obstruction. Bladder outlet obstruction is an in vivo model
(Shakirova et al. 2010) that induces sizeable bladder growth
via mechanical distension of the bladder and that associates
with defined proteomic changes, including STAT3 activation
(Fujita et al. 2006), induction of the endoplasmic reticulum
(ER)-stress markers PDI (protein disulfide isomerase) and
GM130 and repression of contractile markers such as myosin
heavy chain (MYH11) and calponin (CNN1; Krawczyk et al.
2016). Cavin-1 (PTRF) was reduced by bladder outlet ob-
struction and, in keeping with our previous results, cavin-1
was lower in both sham-operated and obstructed KO mice
(Fig. 6a, b). The majority of the remaining changes studied
were unaffected in the absence of cavin-3: phosphorylation of
the pro-proliferative transcription factor STAT3 and induction
of the ER-chaperone PDI were unchanged (Fig. 6a, c), as was
the expression of the cell cycle inhibitor p27KIP (CDKN1B,
Fig. 6a) and repression of the differentiation markers MYH11
and CNN1 (Fig. 6a, e). The only difference was that the Golgi-
associated protein GM130 was less forcefully induced by ob-
struction in the absence of cavin-3 (Fig. 6a, d). In keeping with
Fig. 6 Preserved bladder growth and proteomic response to outlet
obstruction in the absence of cavin-3. WT and KO mice were sham-
operated or subjected to partial bladder outlet obstruction (n = 6 per
group). After 7 days, bladders were harvested and the specified
proteins were determined by Western blotting (a). Some of the
proteomic changes, including changes in PTRF, PY-STAT3, GM130
and calponin, are depicted as bar graphs in b–e. f, g Body weights and
bladder weights in control and obstructedWTand KOmice. h Bladder to
body weight ratio. *P < 0.05, **P < 0.01, ***P < 0.001, n.s. not
significant
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an unchanged proteomic response to obstruction, we found
that bladder growth (Fig. 6f-h) was equivalent in WT and
KO mice. Thus, despite a marginally lower basal phosphory-
lation of ERK and impeded induction of GM130, the overall
growth response of the urinary bladder following outlet ob-
struction remained intact.
Discussion
The current study shows that cavin-3 (PRKCDBP) contributes
to the formation of caveolae in smooth muscle in vivo. Cavin-
3 ablation reduced the density of caveolae in smooth muscle
cells by 40-45%, whereas caveolae abundance was main-
tained in endothelial cells. This difference in dependence on
cavin-3 is probably attributable to the negligible expression of
cavin-3 in endothelial cells, which instead express cavin-2,
albeit in an organ-specific manner (Hansen et al. 2013). A
recent model has suggested that cavins form a net-like lattice
that constitutes the cytoplasmic coat of caveolae (Stoeber et al.
2016). Whether the size of the proposed polyhedral building
blocks of this coat is affected by the cavin composition is un-
known but we note that a difference in the size of caveolae in
endothelial and smooth muscle cells has been reported (Sward
et al. 2014), with a somewhat smaller size distribution of caveo-
lae in smooth muscle compared with in the endothelium. This
differencemight tentatively be dictated by the repertoire of cavins
expressed in the various cell types (cavin-1 and -2 or cavin-1 and
-3) but numerous other factors such as membrane lipid compo-
sition and caveolin isoform expression might also contribute.
A consistent finding in our study was that the lack of cavin-
3 was associated with a reduced level of cavin-1 (PTRF). This
was seen in three different arteries and in the urinary bladder.
A less consistent and smaller, reduction of caveolin-1 was also
seen. Normally, caveolins have a slow turnover rate but when
caveolae formation is disturbed, the rate of degradation is
accelerated. For example, early studies on caveolin-1 KO
mice demonstrated that caveolin-2 was redistributed, possibly
to the Golgi apparatus and degraded (Razani et al. 2001; Drab
et al. 2001). One degradative path of caveolae proteins in-
volves targeting to late endosomes and lysosomes but evi-
dence also suggests the involvement of the proteasome path-
way (Razani et al. 2001; Hayer et al. 2010). The dependence
of caveolins and cavins on higher-order protein assemblies is
further emphasized by the finding that the ablation of cavin-1
destabilizes all caveolins and cavin-2 (Liu and Pilch 2008;
Bastiani et al. 2009). Whether cavin-3 is degraded by ablation
of caveolae might be cell-type-dependent and the knockdown
of cavin-1 has been found to destabilize cavin-3 in 3T3-L1
cells but hardly has any effect on heart and liver (Bastiani et al.
2009). Our own work on cavin-1-deficient urinary bladders
(Karbalaei et al. 2012) and small mesenteric arteries (Sward
et al. 2014) has demonstrated the reduction of cavin-3,
together with all caveolins. From these observations, we infer
that cavin-3 contributes to higher-order protein assemblies in
some cells but not in others and that this is dictated, at least in
part, by its tissue concentration.
A robust finding in our prior studies on small arteries from
caveolin-1 and cavin-1 KO mice was the increased response
to the α1-adrenergic agonist cirazoline, which scaled with an
increased wall thickness (Shakirova et al. 2006; Albinsson
et al. 2007; Sward et al. 2014). This was not seen in the present
work, which also did not reveal a change in arterial dimen-
sions or distensibility, possibly because of the partial loss of
caveolae in contrast with the complete, or almost complete,
loss of caveolae in caveolin-1 and cavin-1 KOs. Alternatively,
the medial remodeling and increased α1-adrenergic respon-
siveness reported in caveolin-1 and cavin-1 KOs might be
indirect and mediated by the loss of caveolae in endothelial
cells. Tissue-specific deletion of caveolin-1 or cavin-1 is re-
quired to distinguish between these possibilities.
Our experiments suggest an increased NO-dependent com-
ponent of relaxation in cavin-3-deficient small arteries.
Numerous prior studies have provided evidence for the acti-
vation of endothelial NO synthase (eNOS) in caveolin-1 KOs
(Razani et al. 2001; Zhao et al. 2002; Desjardins et al. 2008)
and in cavin-1 KOs (Sward et al. 2014), an effect that is con-
sidered to depend on the loss of an inhibitory interaction be-
tween caveolin-1 and eNOS in the endothelium (Kraehling
et al. 2016). Changes at the protein level of Ddah1 and
Arg1, which indirectly impact on eNOS activity, in cavin-1
KOs are expected partly to compensate for this effect (Sward
et al. 2013). Against this background, we were surprised to
find an increased NO-dependent component of relaxation that
was associated with increased sensitivity to SNP and to Bay
41–2272 in a model that uniquely targets caveolae in smooth
muscle. Reported changes of SNP-induced relaxation in
caveolin-1-deficient animals do not seem to be directionally
consistent and both increased (Pojoga et al. 2014) and de-
creased (El-Yazbi et al. 2005) responses have been reported.
We cannot currently explain these results but we should em-
phasize that our findings in cavin-3 KO arteries are internally
consistent, with increased relaxation going hand in hand with
the increased expression of one of the subunits of the sGC. Of
further interest is that L-NAME-resistant relaxation to carba-
chol, which is considered to depend on endothelial-dependent
hyperpolarization (EDH; Figueroa and Duling 2009), is re-
duced. This is in good agreement with the reduction of EDH
seen in global caveolin-1 KO mice (Saliez et al. 2008) and
argues that a defined fraction of the caveolae-dependence of
the EDH mechanism can be ascribed to smooth muscle cells.
Clearly, however, all functional changes that we find at the
resistance artery level are inconsequential for mean arterial
blood pressure, which is well maintained. This is consistent
with the majority of prior studies in caveolin-1-deficient mice
(Rahman and Sward 2009).
Cell Tissue Res
A reduced density of membrane caveolae in cavin-3-KO
mice was not unique for arterial smooth muscle but was also
seen in the urinary bladder. The comparatively large biomass
of the bladder allowed a somewhat more detailed proteomic
characterization, showing a reduction of caveolin-3 in addi-
tion to caveolin-1 and cavin-1. We also considered a number
of proteins recently shown to change after the knockdown of
cavin-3 in fibroblasts (Hernandez et al. 2013) but among
these, only phosphorylated ERK was reduced. This suggests
adaptive mechanisms in live animals. We did not detect any
change in contractility of bladder strips in vitro contrasting
with reported contractile deficits in both caveolin-1-deficient
(Woodman et al. 2004; Sadegh et al. 2011) and cavin-1-
deficient (Karbalaei et al. 2012) detrusors. Because caveolin-
1 staining in the bladder is remarkably specific for the smooth
muscle, with no staining of the urothelium and only faint
staining of the submucosa (Sadegh et al. 2011), we propose
that the unchanged bladder contractility in cavin-3-KO ani-
mals must be attributable to the incomplete ablation of cave-
olae rather than to the lack of changes in other cell types.
Recent studies have renewed interest in caveolae as puta-
tive mechanoprotective organelles that disassemble in re-
sponse to mechanical distension and that act as a membrane
reservoir that protects cells from membrane rupture (Lo et al.
2015; Cheng et al. 2015). The model of partial bladder outlet
obstruction used here is relevant in this regard as it entails
remarkable distension-induced growth and organ remodeling.
Bladder outlet obstruction for 7 days causes a three- to eight-
fold increase in bladder weight, hypertrophy of the detrusor
muscle layer and wide-reaching transcriptomic and proteomic
changes (Krawczyk et al. 2016; Ekman et al. 2013, 2014).
Because the bladder grows to cope with increased mechanical
distension, outlet obstruction should test whether caveolae are
important for chronic mechanical adaptation. Our analyses do
not support this view. We found bladder growth to be very
similar inWTand KOmice, as is STAT3 phosphorylation and
the loss of contractile markers. The only subtle difference is a
curtailed induction of the Golgi protein GM130. We have not
determined the mechanistic basis of this change but one pos-
sibility is that caveolin-1, whose level is better maintained
than that of cavin-1, is partly redistributed to the Golgi appa-
ratus. The presence of caveolin-1 in this membrane might
influence the cleavage of transcription factors such as
Creb3l2, an ER/Golgi-associated transcription factor that con-
trols GM130 (Krawczyk et al. 2016) but this possibility re-
mains to be tested.
To summarize, we identified cavin-3 as a smooth-muscle-
specific cavin that contributes to the formation of caveolae
in vivo. The lack of cavin-3 destabilizes cavin-1 and
caveolin-1 and alters the relative contribution of NO and
endothelial-dependent hyperpolarization to relaxation by
muscarinic receptor activation. This occurs in a setting of
maintained arterial blood pressure. The lack of cavin-3
moreover reduces the density of caveolae in the urinary blad-
der but this is without effect on contractility or mechanically
stimulated growth and protein synthesis.
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